INSERM U643, Nantes, F44000, France.
Immunotherapy. 2011 Apr;3(4 Suppl):35-7. doi: 10.2217/imt.11.37.
Recent studies in the field of CD8(+) Tregs have allowed a better identification and characterization of this subset of regulatory cells. Their key role in the regulation of allogeneic responses is now well established. To take full advantage of CD8(+) Treg cells in future therapeutic applications, a better knowledge is required, particularly concerning the contribution of the T-cell receptor (TCR) in cell function as well as the role and importance of its antigenic specificity. Here, we focused on the CD8(+)CD45RC(low) Tregs, which in rats induce an indefinite long-term allograft acceptance. We summarized recent findings on their interaction properties with antigen-presenting cells. Identification of the antigenic targets and TCR repertoire of CD8(+) Tregs will allow a better understanding of their recognition properties and will highlight the potential of such of specific population in cell-based treatment.
最近在 CD8(+)Tregs 领域的研究使人们能够更好地识别和描述这种调节性细胞亚群。它们在调节同种异体反应中的关键作用现在已经得到充分证实。为了在未来的治疗应用中充分利用 CD8(+)Treg 细胞,需要更好地了解它们,特别是关于 T 细胞受体 (TCR) 在细胞功能中的作用,以及其抗原特异性的作用和重要性。在这里,我们关注的是 CD8(+)CD45RC(low)Tregs,它们在大鼠中诱导长期的同种异体移植物接受。我们总结了最近关于它们与抗原呈递细胞相互作用特性的发现。鉴定 CD8(+)Treg 的抗原靶标和 TCR 库将有助于更好地了解它们的识别特性,并突出这种特定群体在基于细胞的治疗中的潜力。